This April 24th and 25th, the Swiss Biotech Day exhibition was held. Organized by the Swiss Biotech Association (SBA), it took place in Basel, the Swiss city considered the European capital of the pharmaceutical industry.
The Swiss Biotech Day Exhibition is one of the most important events in the Swiss biotechnology sector. It brings together hundreds of companies, researchers, and investors from the biotech industry each year to discuss the latest trends, technological advances, and innovations.
At Swiss Biotech Day, participants can attend presentations by company executives and opinion leaders, roundtable discussions, exhibitions, and B2B meetings.
One of the highlights of Swiss Biotech is the quality of its conferences. Industry experts, scientists, and investors present on topics such as drug discovery, emerging technologies, regulation, biotech companies’ investments, and market trends.
The exhibition provides a unique platform for exhibitors and attendees to meet potential partners, share knowledge, and network with industry leaders. In addition, participants can attend conferences and seminars, participate in networking sessions, and discover the latest innovations in products and services.
Exhibiting companies use the opportunity to showcase their innovative products, services, and technologies, as well as to promote their brand and strengthen their image. Many companies also use the opportunity to launch new products or services.
For GxpManager, it was an intensive day and a half: many meetings with small and medium-sized biotechs with QMS-4-SME interests.
According to Elisabeth, it was a very interesting and well-organized fair in the beautiful city of Basel. They had the opportunity to meet international life science actors and understand our clients’ new emerging needs.
Thanks to this exhibition, GxpManager was able to network in the European biotech field with industry professionals, researchers, investors, and entrepreneurs.
It also increased GxpManager’s visibility as we were able to present our SaaS platform and applications.
Our collaborators were able to discuss the challenges faced by the biotech industry and to find innovative solutions to overcome them, such as GxpManager’s Low-Code-No-Code solutions.